The Daily Shot Brief – October 13th, 2020



Equities: The market is behaving as if the coronavirus problem is all but gone. The assumption is that the vaccine will be available soon, will be effective, and most people will be inoculated. There is, however, a substantial risk associated with each of these assumptions.

 Vaccine timing remains uncertain.

Source: STAT Read full article


 COVID vaccine effectiveness and the immune response longevity are unknown at this point.

Source: BBC Read full article


Credit: Corporate loan balances at US banks continue to shrink as companies pay down their drawn credit lines.

Source: FRED


Energy: OECD oil demand peaked some 15 years ago and is expected to keep falling.

Source: @WSJ Read full article


Eurozone: Here is the distribution of Italy’s trade with the US.

Source: Atlantic Council Read full article


United States: A weaker US dollar and the stock market rally have significantly eased US financial conditions.

Source: Goldman Sachs


Food For Thought: Support for Obamacare:

Source: @MorningConsult, @mg_galvin Read full article

Edited by Devon Lall

Contact the Daily Shot Editor:

Dear Friends,

The full-length Daily Shot® is now an independent ad-free publication (see Here is a sample newsletter.

Daily Shot Brief subscribers are eligible to receive the full-length Daily Shot for $115/year (a $20 discount).

To subscribe with this discount, you must register here (NOTE: The regular subscription page will not acknowledge this coupon).  The coupon number is DSB329075 (please click the “apply” button for the discount to take effect).

A monthly subscription is also available (here).

The Food for Thought section is available as a separate newsletter. You can sign up here.

Please note that The Daily Shot is not an investment newsletter and is not intended for broad distribution.

If you have any questions, please contact


Lev Borodovsky
Editor, The Daily Shot

Leave a Reply